vs

Side-by-side financial comparison of C4 Therapeutics, Inc. (CCCC) and STRATUS PROPERTIES INC (STRS). Click either name above to swap in a different company.

C4 Therapeutics, Inc. is the larger business by last-quarter revenue ($11.0M vs $8.3M, roughly 1.3× STRATUS PROPERTIES INC). STRATUS PROPERTIES INC runs the higher net margin — 203.2% vs -186.0%, a 389.2% gap on every dollar of revenue. On growth, C4 Therapeutics, Inc. posted the faster year-over-year revenue change (112.8% vs -19.4%). Over the past eight quarters, C4 Therapeutics, Inc.'s revenue compounded faster (90.4% CAGR vs -44.1%).

C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted protein degradation therapies for cancer and other severe diseases with high unmet medical needs. It leverages its proprietary TORPEDO platform to design small molecule degraders that eliminate disease-causing proteins, with a pipeline of oncology candidates in preclinical and clinical development, plus strategic partnerships with leading global pharmaceutical firms.

Ryman Hospitality Properties, Inc. is a hotel, resort, entertainment, and media company named for one of its assets: the Ryman Auditorium, a National Historic Landmark in Nashville, Tennessee. The company's legal lineage can be traced back to its time as a subsidiary of Edward Gaylord's Oklahoma Publishing Company; however, the backbone of the modern entity was formed with the company's acquisition of WSM, Inc. in 1983. This purchase resulted in the ownership of the Grand Ole Opry and associa...

CCCC vs STRS — Head-to-Head

Bigger by revenue
CCCC
CCCC
1.3× larger
CCCC
$11.0M
$8.3M
STRS
Growing faster (revenue YoY)
CCCC
CCCC
+132.2% gap
CCCC
112.8%
-19.4%
STRS
Higher net margin
STRS
STRS
389.2% more per $
STRS
203.2%
-186.0%
CCCC
Faster 2-yr revenue CAGR
CCCC
CCCC
Annualised
CCCC
90.4%
-44.1%
STRS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCCC
CCCC
STRS
STRS
Revenue
$11.0M
$8.3M
Net Profit
$-20.5M
$16.9M
Gross Margin
Operating Margin
-210.1%
Net Margin
-186.0%
203.2%
Revenue YoY
112.8%
-19.4%
Net Profit YoY
40.7%
1293.4%
EPS (diluted)
$-0.09
$2.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCCC
CCCC
STRS
STRS
Q4 25
$11.0M
$8.3M
Q3 25
$11.2M
$5.0M
Q2 25
$6.5M
$11.6M
Q1 25
$7.2M
$5.0M
Q4 24
$5.2M
$10.3M
Q3 24
$15.4M
$8.9M
Q2 24
$12.0M
$8.5M
Q1 24
$3.0M
$26.5M
Net Profit
CCCC
CCCC
STRS
STRS
Q4 25
$-20.5M
$16.9M
Q3 25
$-32.2M
$-8.0M
Q2 25
$-26.0M
$-2.3M
Q1 25
$-26.3M
$-3.8M
Q4 24
$-34.6M
$-1.4M
Q3 24
$-24.7M
$-1.4M
Q2 24
$-17.7M
$-2.8M
Q1 24
$-28.4M
$3.7M
Gross Margin
CCCC
CCCC
STRS
STRS
Q4 25
Q3 25
-85.1%
Q2 25
-19.0%
Q1 25
5.1%
Q4 24
18.3%
Q3 24
2.5%
Q2 24
10.9%
Q1 24
30.7%
Operating Margin
CCCC
CCCC
STRS
STRS
Q4 25
-210.1%
Q3 25
-306.4%
-162.9%
Q2 25
-441.0%
-6.5%
Q1 25
-402.9%
-71.3%
Q4 24
-728.4%
-13.6%
Q3 24
-183.9%
-17.1%
Q2 24
-178.6%
-34.4%
Q1 24
-1060.2%
13.9%
Net Margin
CCCC
CCCC
STRS
STRS
Q4 25
-186.0%
203.2%
Q3 25
-286.4%
-161.1%
Q2 25
-402.6%
-19.8%
Q1 25
-363.7%
-74.5%
Q4 24
-667.8%
-13.7%
Q3 24
-160.6%
-15.9%
Q2 24
-147.6%
-32.7%
Q1 24
-933.2%
13.9%
EPS (diluted)
CCCC
CCCC
STRS
STRS
Q4 25
$-0.09
$2.42
Q3 25
$-0.44
$-0.62
Q2 25
$-0.37
$0.03
Q1 25
$-0.37
$-0.36
Q4 24
$-0.50
$-0.06
Q3 24
$-0.35
$-0.05
Q2 24
$-0.26
$-0.21
Q1 24
$-0.41
$0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCCC
CCCC
STRS
STRS
Cash + ST InvestmentsLiquidity on hand
$74.6M
$74.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$256.6M
$204.5M
Total Assets
$359.1M
$563.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCCC
CCCC
STRS
STRS
Q4 25
$74.6M
$74.3M
Q3 25
$58.8M
$55.0M
Q2 25
$78.2M
$59.4M
Q1 25
$51.3M
$12.0M
Q4 24
$55.5M
$20.2M
Q3 24
$59.6M
$19.6M
Q2 24
$73.1M
$13.5M
Q1 24
$89.7M
$20.7M
Stockholders' Equity
CCCC
CCCC
STRS
STRS
Q4 25
$256.6M
$204.5M
Q3 25
$154.4M
$185.8M
Q2 25
$174.1M
$191.9M
Q1 25
$195.1M
$191.5M
Q4 24
$216.0M
$194.7M
Q3 24
$242.7M
$196.4M
Q2 24
$247.1M
$196.3M
Q1 24
$258.3M
$197.6M
Total Assets
CCCC
CCCC
STRS
STRS
Q4 25
$359.1M
$563.4M
Q3 25
$265.5M
$572.6M
Q2 25
$296.5M
$574.8M
Q1 25
$319.5M
$534.6M
Q4 24
$349.6M
$532.6M
Q3 24
$376.1M
$523.2M
Q2 24
$381.1M
$514.0M
Q1 24
$398.4M
$509.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCCC
CCCC
STRS
STRS
Operating Cash FlowLast quarter
$-22.1M
$-29.9M
Free Cash FlowOCF − Capex
$-38.0M
FCF MarginFCF / Revenue
-458.5%
Capex IntensityCapex / Revenue
98.2%
Cash ConversionOCF / Net Profit
-1.77×
TTM Free Cash FlowTrailing 4 quarters
$-70.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCCC
CCCC
STRS
STRS
Q4 25
$-22.1M
$-29.9M
Q3 25
$-31.2M
$-9.0M
Q2 25
$-12.1M
$-1.7M
Q1 25
$-33.3M
$-13.5M
Q4 24
$-17.9M
$-5.8M
Q3 24
$-24.1M
$-686.0K
Q2 24
$-5.0M
$-8.3M
Q1 24
$-18.1M
$6.5M
Free Cash Flow
CCCC
CCCC
STRS
STRS
Q4 25
$-38.0M
Q3 25
$-31.6M
$-9.9M
Q2 25
$-4.3M
Q1 25
$-18.0M
Q4 24
$-17.9M
$-35.0M
Q3 24
$-24.1M
$-7.5M
Q2 24
$-5.2M
$-16.3M
Q1 24
$-1.6M
FCF Margin
CCCC
CCCC
STRS
STRS
Q4 25
-458.5%
Q3 25
-281.5%
-198.7%
Q2 25
-37.2%
Q1 25
-357.4%
Q4 24
-346.5%
-339.7%
Q3 24
-157.2%
-84.4%
Q2 24
-43.1%
-191.6%
Q1 24
-6.0%
Capex Intensity
CCCC
CCCC
STRS
STRS
Q4 25
98.2%
Q3 25
3.7%
18.4%
Q2 25
22.7%
Q1 25
89.8%
Q4 24
0.1%
283.0%
Q3 24
0.1%
76.7%
Q2 24
1.6%
94.2%
Q1 24
0.0%
30.7%
Cash Conversion
CCCC
CCCC
STRS
STRS
Q4 25
-1.77×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
1.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons